Avanos Medical Inc
NYSE:AVNS

Watchlist Manager
Avanos Medical Inc Logo
Avanos Medical Inc
NYSE:AVNS
Watchlist
Price: 12.89 USD 0.31% Market Closed
Market Cap: $598.4m

Relative Value

The Relative Value of one AVNS stock under the Base Case scenario is 23.66 USD. Compared to the current market price of 12.89 USD, Avanos Medical Inc is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AVNS Relative Value
Base Case
23.66 USD
Undervaluation 46%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

AVNS Competitors Multiples
Avanos Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Avanos Medical Inc
NYSE:AVNS
598.3m USD 0.9 -1.3 8.7 19.9
JP
Hoya Corp
TSE:7741
8.8T JPY 9.9 42.1 26.1 31.3
CH
Alcon AG
SIX:ALC
30.9B CHF 3.9 38.1 19.9 38.7
US
Medline Inc
NASDAQ:MDLN
35.5B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
122.3B DKK 4.4 33.6 15.5 18.4
US
Align Technology Inc
NASDAQ:ALGN
11.7B USD 2.9 30.9 14 17.8
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.7 29.4 17.7 28.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.9B CNY 9.4 25.8 23.2 23.2
KR
HLB Inc
KOSDAQ:028300
7.3T KRW 83.6 -30.7 -76.7 -72.6
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 1.2 -19.4 19.4 91.5
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF 5.3 21.7 14.1 19.1
P/E Multiple
Earnings Growth PEG
US
Avanos Medical Inc
NYSE:AVNS
Average P/E: 31.7
Negative Multiple: -1.3
N/A N/A
JP
Hoya Corp
TSE:7741
42.1
13%
3.2
CH
Alcon AG
SIX:ALC
38.1
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
33.6
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
30.9
27%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
29.4
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.8
9%
2.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -30.7 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.4 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
21.7
32%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Avanos Medical Inc
NYSE:AVNS
Average EV/EBITDA: 17.6
8.7
26%
0.3
JP
Hoya Corp
TSE:7741
26.1
11%
2.4
CH
Alcon AG
SIX:ALC
19.9
8%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.5
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
14
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
17.7
10%
1.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.2
15%
1.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -76.7 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
19.4
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
14.1
21%
0.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Avanos Medical Inc
NYSE:AVNS
Average EV/EBIT: 32.1
19.9
51%
0.4
JP
Hoya Corp
TSE:7741
31.3
N/A N/A
CH
Alcon AG
SIX:ALC
38.7
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.4
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
17.8
16%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
28.8
22%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.2
11%
2.1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -72.6 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
91.5
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
19.1
29%
0.7